(Q38062614)

28 August 2017

title

Antibody-mediated vascular rejection of kidney allografts: a population-based study. (English)

1 reference

28 August 2017

1 reference

10

Patrick Bruneval

1 reference

28 August 2017

3

Dewi Vernerey

1 reference

28 August 2017

Carmen Lefaucheur

1

1 reference

28 August 2017

Alexandre Loupy

2

1 reference

28 August 2017

Jean-Paul Duong-Van-Huyen

4

1 reference

28 August 2017

Caroline Suberbielle

5

1 reference

28 August 2017

Dany Anglicheau

6

1 reference

28 August 2017

Jérôme Vérine

7

1 reference

28 August 2017

Thibaut Beuscart

8

1 reference

28 August 2017

Dominique Nochy

9

1 reference

28 August 2017

Dominique Charron

11

1 reference

28 August 2017

Michel Delahousse

12

1 reference

28 August 2017

Jean-Philippe Empana

13

1 reference

28 August 2017

Gary S Hill

14

1 reference

28 August 2017

Denis Glotz

15

1 reference

28 August 2017

Christophe Legendre

16

1 reference

28 August 2017

Xavier Jouven

17

1 reference

28 August 2017

language of work or name

English

0 references

publication date

23 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

381

1 reference

28 August 2017

issue

9863

1 reference

28 August 2017

page(s)

313-319

1 reference

The quality of life of patients with end-stage renal disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

The global role of kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Rejection of the kidney allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Banff 07 classification of renal allograft pathology: updates and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Determinants of poor graft outcome in patients with antibody-mediated acute rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Graft vasculopathy in clinical hand transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Evaluation of c4d deposition and circulating antibody in small bowel transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

B cell depletion reduces the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Long-term renal allograft survival in the United States: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Java Treeview--extensible visualization of microarray data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Clinicopathological analysis of acute vascular rejection cases after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Immunosuppressive drugs for kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Rituximab therapy for acute humoral rejection after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

National conference to assess antibody-mediated rejection in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961265-3

7 January 2021

10.1016/S0140-6736(12)61265-3

Identifiers

DOI

1 reference

28 August 2017

1 reference